Cyclophosphamide, Topotecan, and Bevacizumab (CTB) in Patients With Relapsed/Refractory Ewing's Sarcoma and Neuroblastoma
Clinical trial NCT01492673 · COMPLETED
Trial details
- NCT number
- NCT01492673
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-01
- Primary completion
- 2018-10-31
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.